Despite a scientific history spanning barely five decades, the field of alcohol and drugs is now a legitimate medical subspecialty. The conceptual base is developing, evidence-based approaches are being used, and more effective interventions are now available.1 With the first adoption of a scientific perspective came the development of more rigorous diagnosis and several robust screening questionnaires, which have proved valuable in research but are not yet widely used in clinical practice. Progress has been made in improving detection rates and in providing interventions for at-risk patients. Now, the Royal Australasian College of Physicians is establishing a Chapter of Addiction Medicine, reflecting the growing scientific base of the alcohol and drug field and paving the way for future expansion.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- Alcohol and Drug Service, St Vincent's Hospital, Darlinghurst, NSW 2010.
- 1. Gowing L, Proudfoot H, Henry-Edwards S, Teesson M. Evidence supporting treatment. The effectiveness of interventions for illicit drug use. Woden, ACT: Australian National Council on Drugs, 2001.
- 2. Sass H, Soyka M, Mann K, Zeiglgänsberger W. Relapse prevention by acamprosate. Arch Gen Psychiatry 1996; 53: 673-680.
- 3. Jorenby DE, Leischow SJ, Nides MA, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999; 340: 685-691.
- 4. Wodak A, Hall W. Buprenorphine: better late than never. Med J Aust 2001; 175: 349-350.
- 5. Shearer J, Wodak A, Mattick RP, et al. Pilot randomized controlled trial of dexamphetamine substitution for amphetamine dependence. Addiction 2001; 96: 1289-1296.